SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute
infections have long been associated with an unexplained chronic disability in a minority of …

Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

D-dimer is a fibrin degradation product encompassing multiple cross-linked D domains
and/or E domains present in the original fibrinogen molecule, whose generation is only …

Immunothrombosis—immune-mediated activation of coagulation—is protective against
pathogens, but excessive immunothrombosis can result in pathological thrombosis and …

This case presents a patient with severe COVID-19 pneumonia requiring intensive care unit
admission and a prolonged hospital stay. The infection resulted in long-term morbidity …

Venous thromboembolism (VTE) remains a major health burden despite anticoagulation
advances, suggesting incomplete management of pathogenic mechanisms. The NLRP3 …

Coronavirus disease 2019 (COVID-19) is associated with an increased risk of venous
thromboembolism (VTE) and coagulopathy, especially in critically ill patients. Endothelial …

Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events,
especially in patients with severe infections requiring intensive care and cardiorespiratory …

Background The effect of extended thromboprophylaxis in improving the prognosis of adult
patients with coronavirus disease 2019 (COVID-19) after discharge remains debatable. This …

Many studies have identified predictors of outcomes for inpatients with coronavirus disease
2019 (COVID-19), especially in intensive care units. However, most retrospective studies …